How BAF Mutations Drive Cancer Development and Growth
Researchers identified a molecular mechanism that could offer new therapeutic targets for patients with BAF-mutant cancers.
Updated on Oct. 28, 2026 in Cancer
Live Poll
Should more funding be directed toward research targeting fundamental cellular mechanisms in cancer?
Weill Cornell Medicine researchers have identified a mechanism where BAF complex mutations cause cancer by altering DNA structure. This finding explains how these mutations, found in 20% of human cancers, drive malignancy by promoting uncontrolled cell division.
Why it matters
Understanding this molecular shift may open new pathways for treating cancers like lymphoma, breast, and liver, which are often driven by BAF mutations. By identifying specific protein targets, researchers aim to eventually develop therapies that reverse these malignancy-promoting effects.
A preclinical study published in Nature found that BAF mutations cause cancer by opening DNA loops and increasing CTCF protein binding. In animal models, researchers demonstrated that deleting CTCF reversed these cancer-promoting effects, though human clinical outcomes are unknown.
The players
Weill Cornell Medicine
A biomedical research institution and medical school that focuses on advancing cancer genetics and therapeutic development.
The details
The BAF complex normally regulates gene expression, but when mutated, it fails to maintain the correct three-dimensional structure of DNA. This loss of function allows the protein CTCF to bind to thousands of additional sites, effectively reshaping DNA loops and turning on genes that drive rapid cell division. Researchers also identified protein complexes PBAF and ISWI as key partners to CTCF, marking them as potential future therapeutic targets.
Timeline
October 28, 2026: Study published in Nature journal.
Health Landscape
This research provides a new understanding of chromatin architecture in cancer, building upon the established goal of targeting structural DNA changes. It sits within a broader scientific trend aiming to move beyond traditional chemotherapy toward precision therapies that address specific genetic drivers.
While these findings are an early research discovery, they highlight why genetic testing is increasingly important for understanding specific cancer drivers. Patients currently managing cancer are encouraged to speak with their oncologist about whether their diagnosis involves BAF complex mutations.
The takeaway
Mutations in the BAF complex alter DNA loops, causing cells to divide uncontrollably and fueling various cancers. Tracking your own genetic pathology reports and discussing specific mutation markers with your physician can provide greater clarity on your personal health profile and future treatment options.
Further reading
For more on the current understanding of oncogenic processes, explore our resources on Cancer.
More information
Read the full results of the Nature study on chromatin architecture.
Source note: This article includes information reported by News-Medical.
Live Poll
Should more funding be directed toward research targeting fundamental cellular mechanisms in cancer?
